
T-Vobit 1 Tablet SR
Marketer
Lupin Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview T-Vobit 1 Tablet SR
DiaVance-1 Extended Release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. DiaVance-1 Extended Release should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your glycemic response. Continuous use is crucial; discontinuation without physician consultation can lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect of DiaVance-1 Extended Release. Learn to recognize its symptoms—sweating, dizziness, headache, and tremors—and how to treat them. Maintain regular mealtimes and always carry a readily available fast-acting glucose source, like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Routine blood glucose monitoring is necessary, and your doctor may order blood tests to evaluate blood cell counts and liver function.
Uses of T-Vobit 1 Tablet SR
Managing type 2 diabetes
Major Benefits of T-Vobit 1 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer T-Vobit 1 Tablet SR on an empty stomach.
Common Side effects of T-Vobit 1 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use T-Vobit 1 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Administer T-Vobit 1 Tablet SR on an empty stomach.
How T-Vobit 1 Tablet SR works:
One sustained-release T-Vobit tablet combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and T-Vobit 1 Tablet SR is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of T-Vobit 1 Tablet SR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release T-Vobit 1 tablet is likely unsuitable for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney impairment should likely avoid T-Vobit 1 Tablet SR, as its use may be unsafe. Medical advice is recommended. Furthermore, this medication is not advised for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use T-Vobit 1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, a low initial dose is typically advised; however, its use is contraindicated in patients with severe liver disease.
What if you forget to take T-Vobit 1 Tablet SR :
Should you forget to take a T-Vobit 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About T-Vobit 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
